BIO-Europe Spring(R) Remains Europe’s Largest and Most International Biopharma Industry Gathering this Spring

3 years ago

Statistics show half of all meetings are already agreed upon 2 weeks before the eventMUNICH, GERMANY / ACCESSWIRE / February…

Avant Brands Announces Timing of Release of 2021 Annual Results and Conference Call

3 years ago

KELOWNA, BC / ACCESSWIRE / February 10, 2022 / Avant Brands Inc. (TSX:AVNT) (OTCQX:AVTBF) (FRA:1BUP) ("Avant" or the "Company"), an…

Dynatronics Corporation Reports Second Quarter Financial Results and Business Highlights

3 years ago

EAGAN, MN / ACCESSWIRE / February 10, 2022 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy,…

CureVac Doses First Participant in Phase 1 Study with Multivalent Influenza Vaccine Candidate Based on Second-Generation mRNA Backbone Developed in Collaboration with GSK

3 years ago

- Multivalent technology approach for seasonal influenza mRNA vaccine candidate addressing four different influenza strains- Influenza candidate developed in collaboration…

Latina-Led Respira Labs Raises $2.8 Million to Revolutionize Respiratory Care for COPD, COVID-19 and Asthma Patients

3 years ago

The funding is a major win for a standout medtech startup and U.S. Latinx startup community; allows the company to…

Vericel to Report Fourth-Quarter 2021 Financial Results on February 24, 2022

3 years ago

CAMBRIDGE, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine…

Vera Therapeutics Announces Pricing of Upsized Public Offering of Class A Common Stock

3 years ago

BRISBANE, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (“Vera”) (Nasdaq: VERA), a late-stage biotechnology company focused on…

Vaxcyte to Present at the 11th Annual SVB Leerink Global Healthcare Conference

3 years ago

SAN CARLOS, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a vaccine innovation company engineering high-fidelity vaccines…

Dyadic and Phibro Animal Health Announce Exclusive License Agreement to Develop and Commercialize Animal Health Vaccine

3 years ago

The exclusive license agreement between Dyadic and Phibro utilizes Dyadic engineered C1-cells to produce specific targeted antigens for development and…

TransCode Therapeutics to Present at 2020 BIO CEO & INVESTOR CONFERENCE

3 years ago

BOSTON, Feb. 10, 2022 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) today announced that it will be presenting at…